bn:16774031n
Noun Concept
Categories: Secondary amines, Long-acting beta2-adrenergic agonists, Phenylethanolamines, Respiratory system drug stubs, Chloroarenes
EN
vilanterol  4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol  C24H33Cl2NO5  GW-642444x  GW642444X
EN
Vilanterol is an ultra-long-acting β2 adrenoreceptor agonist, which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease .. Wikipedia
Definitions
Relations
Sources
EN
Vilanterol is an ultra-long-acting β2 adrenoreceptor agonist, which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease .. Wikipedia
Pharmaceutical drug Wikidata